Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

by Gruel, Y. , Medcalf, R. L. , Dogné, J. M. , Lippi, G. , Douxfils, J. , Chatelain, B. , Testa, S. , Lessire, S. , Gouin-Thibault, I. , Mullier, F. , Hardy, M. , ten Cate, H. , Lecompte, T.

in Angiology / Anticoagulants / Anticoagulation / Blood tests / Cardiology / Coagulopathy / Coronaviruses / COVID-19 / D-dimers / Fibrin / Hematology / Hemostasis / Life Sciences / Medicine / Medicine & Public Health / Mortality / Prothrombin / Review / Thrombin / Thromboembolism / Thrombosis

2020

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

by Gruel, Y. , Medcalf, R. L. , Dogné, J. M. , Lippi, G. , Douxfils, J. , Chatelain, B. , Testa, S. , Lessire, S. , Gouin-Thibault, I. , Mullier, F. , Hardy, M. , ten Cate, H. , Lecompte, T.

2020

Confirm

Do you wish to request the book?

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

by Gruel, Y. , Medcalf, R. L. , Dogné, J. M. , Lippi, G. , Douxfils, J. , Chatelain, B. , Testa, S. , Lessire, S. , Gouin-Thibault, I. , Mullier, F. , Hardy, M. , ten Cate, H. , Lecompte, T.

2020

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Gruel, Y.,

Medcalf, R. L.,

Dogné, J. M.,

Lippi, G.,

Douxfils, J.,

Chatelain, B.,

Testa, S.,

Lessire, S.,

Gouin-Thibault, I.,

Mullier, F.,

Hardy, M.,

ten Cate, H.,

Lecompte, T.

2020

Overview

Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of thromboembolic events has been reported despite thromboprophylaxis, raising the question of a more effective anticoagulation. First-line hemostasis tests such as activated partial thromboplastin time, prothrombin time, fibrinogen and D-dimers are proposed for assessing thrombotic risk and monitoring hemostasis, but are vulnerable to many drawbacks affecting their reliability and clinical relevance. Specialized hemostasis-related tests (soluble fibrin complexes, tests assessing fibrinolytic capacity, viscoelastic tests, thrombin generation) may have an interest to assess the thrombotic risk associated with COVID-19. Another challenge for the hemostasis laboratory is the monitoring of heparin treatment, especially unfractionated heparin in the setting of an extreme inflammatory response. This review aimed at evaluating the role of hemostasis tests in the management of COVID-19 and discussing their main limitations.

Share this book

Add to My Shelf

Publisher

BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC

Subject